(Q36564971)

15 August 2017

1 reference

title

Biological therapy in the management of recent-onset Crohn's disease: why, when and how? (English)

1 reference

15 August 2017

0 references

Maikel P Peppelenbosch

object named as

Maikel Peppelenbosch

series ordinal

2

0 references

author name string

Mark Löwenberg

series ordinal

1

1 reference

15 August 2017

Daniel Hommes

series ordinal

3

1 reference

15 August 2017

publication date

1 January 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

66

1 reference

15 August 2017

issue

11

1 reference

15 August 2017

page(s)

1431-1439

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200666110-00002

15 August 2017

exact match

0 references

cites work

Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666110-00002

Respiratory tolerance is inhibited by the administration of corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666110-00002

Specific inhibition of c-Raf activity by semapimod induces clinical remission in severe Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666110-00002

Azathioprine suppresses ezrin-radixin-moesin-dependent T cell-APC conjugation through inhibition of Vav guanosine exchange activity on Rac proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666110-00002

Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen

21 January 2018

1 reference

12 December 2020

Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.

1 reference

12 December 2020

Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County

1 reference

12 December 2020

Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity

1 reference

12 December 2020

Autoimmunity through cytokine-induced dendritic cell activation

1 reference

12 December 2020

Biologic therapy for inflammatory bowel disease.

1 reference

12 December 2020

Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity

1 reference

12 December 2020

Anatomical basis of tolerance and immunity to intestinal antigens

1 reference

12 December 2020

1 reference

12 December 2020

Glucocorticoid inhibition of lymphokine secretion by alloreactive T lymphocyte clones.

1 reference

12 December 2020

Fas and Fas ligand: lpr and gld mutations

1 reference

12 December 2020

A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death

1 reference

12 December 2020

European evidence based consensus on the diagnosis and management of Crohn's disease: current management.

1 reference

12 December 2020

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

1 reference

12 December 2020

A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators

1 reference

12 December 2020

1 reference

12 December 2020

6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity

1 reference

12 December 2020

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

12 December 2020

Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn's disease

1 reference

12 December 2020

Intestinal epithelial TOLLerance versus inTOLLerance of commensals

1 reference

12 December 2020

Dysregulation of intestinal mucosal immunity: implications in inflammatory bowel disease

1 reference

12 December 2020

Pathways of apoptosis in lymphocyte development, homeostasis, and disease

1 reference

12 December 2020

Evidence that apoptosis of activated T cells occurs in spontaneous tolerance of liver allografts and is blocked by manipulations which break tolerance

1 reference

12 December 2020

A randomized placebo-controlled trial of a humanized monoclonal antibody to alpha4 integrin in active Crohn's disease.

1 reference

12 December 2020

Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis

1 reference

12 December 2020

Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease

1 reference

12 December 2020

Frequency of glucocorticoid resistance and dependency in Crohn's disease

1 reference

12 December 2020

Gamma interferon augments the intracellular pathway for lipopolysaccharide (LPS) recognition in human intestinal epithelial cells through coordinated up-regulation of LPS uptake and expression of the intracellular Toll-like receptor 4-MD-2 complex

1 reference

12 December 2020

CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes

1 reference

12 December 2020

Mitogen-activated protein kinases

1 reference

12 December 2020

Commensal host-bacterial relationships in the gut

1 reference

12 December 2020

Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohort

1 reference

12 December 2020

Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity

1 reference

12 December 2020

Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.

1 reference

12 December 2020

Tolerogenic dendritic cells

1 reference

12 December 2020

Pharmacological inhibition of programmed lymphocyte death

1 reference

12 December 2020

Inflammatory bowel disease: autoimmune or immune-mediated pathogenesis?

1 reference

12 December 2020

Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease

1 reference

12 December 2020

Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study

1 reference

12 December 2020

The anatomical basis of intestinal immunity

1 reference

12 December 2020

Dexamethasone-mediated inhibition of human T cell growth factor and gamma-interferon messenger RNA

1 reference

12 December 2020

Methotrexate for the Treatment of Crohn's Disease

1 reference

12 December 2020

Therapeutic modulation of signal transduction pathways.

1 reference

12 December 2020

Infliximab is the drug we have been waiting for in Crohn's disease

1 reference

12 December 2020

Azathioprine in steroid-resistant and steroid-dependent ulcerative colitis

1 reference

12 December 2020

Fas/Fas ligand deficiency results in altered localization of anti-double-stranded DNA B cells and dendritic cells

1 reference

12 December 2020

National Cooperative Crohn's Disease Study: results of drug treatment

1 reference

12 December 2020

Infliximab for the treatment of fistulas in patients with Crohn's disease

1 reference

12 December 2020

Infliximab: mechanism of action beyond TNF-alpha neutralization in inflammatory bowel disease

1 reference

12 December 2020

TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells

1 reference

12 December 2020

A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease

1 reference

12 December 2020

Dendritic cell apoptosis in the maintenance of immune tolerance

1 reference

12 December 2020

European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment

1 reference

12 December 2020

The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients

1 reference

12 December 2020

Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II

1 reference

12 December 2020

The immune tolerance network: a new paradigm for developing tolerance-inducing therapies

1 reference

12 December 2020

Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment

1 reference

12 December 2020

Natalizumab for active Crohn's disease

1 reference

12 December 2020

Strategic compartmentalization of Toll-like receptor 4 in the mouse gut

1 reference

12 December 2020

Immunogenicity of biological agents in inflammatory bowel disease

1 reference

12 December 2020

Infliximab induces apoptosis of monocytes and T lymphocytes in a human-mouse chimeric model

1 reference

12 December 2020

Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue

1 reference

12 December 2020

Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance.

1 reference

12 December 2020

Regulation of T cell immunity by dendritic cells

1 reference

12 December 2020

Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis

1 reference

12 December 2020

10.2165/00003495-200666110-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

15 August 2017

1029680796

0 references

1 reference